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Aims
Mitochondrial diseases are a heterogeneous group of
genetic disorders that result from dysfunction of the
respiratory chain. The endocrine disorders such as dia-
betes mellitus, hypoparathyroidism, hypothyroidism and
growth hormone deficiency have been described in
patients with mitochondrial DNA mutations. Among
these, patients with Mitochondrial Encephalomyopathy,
Lactic Acidosis, and Stroke-like episodes (MELAS) fre-
quently present with mitochondrial diabetes. Thus, this
study was performed to investigate endocrine dysfunc-
tions in patients with mitochondrial diseases.
Methods
A total of 106 patients (65 males and 41 females) diagnosed
with mitochondrial diseases were included. Their etiologies
were confirmed by clinical features and mitochondrial gene
sequencing: Leber Hereditary Optic Neuropathy (LHON)
(56 patients, 52.8%), MELAS (33 patients, 31.1%), Leigh
disease (7 patients, 6.6%), Myoclonic Epilepsy with Ragged
Red Fibers (MERRF) (7 patients, 6.6%), Pearson syndrome
(2 patients, 0.02%) and Kearns-Sayre syndrome (KSS)
(1 patient, 0.9%). Clinical, auxological and endocrinological
parameters such as weight, height, body mass index (BMI),
serum free T4, thyroid stimulating hormone (TSH), and
glycosylated hemoglobin (HbA1c) were analyzed. Their
medical records were reviewed retrospectively.
Results
Endocrine dysfunctions were observed in 19 patients
(19/33, 57.6%) with MELAS,1 patient with KSS and
Pearson disease, respectively. In patients with MELAS,
mean age at diagnosis was 15.2 ± 10.7 years (range,
8 month to 36 years). Their mean height, weight, and
BMI were 139.0 ± 20.1 cm (- 2.54 SDS), 30.0 ± 11.6 kg
(- 4.43 SDS) and 15.7 ± 3.4 kg/m2 (- 2.18 SDS), respec-
tively. Mean HbA1c was 6.59 ± 1.81% in 24 patients
with MELAS who showed hyperglycemia in routine
serum chemical tests. Thyroid functions were normal in
all patients. In mitochondrial gene analysis of MELAS,
mt.3243 A>G was the most common (23/33 alleles,
69.7%), followed by mt.3316A>T (1 alleles),
mt.13513G>A (1 allele), mt.8363G>A (2 allele), and
mitochondrial DNA deletion (1 allele). One patient with
KSS showed hypocalcemia with low parathyroid hor-
mone level and stunted growth velocity. A Pearson syn-
drome patient manifested adrenal insufficiency.
Endocrine dysfunctions were not found in the other
mitochondrial diseases including LHON, Leigh disease,
and MERRF.
Conclusion
Endocrine dysfunctions and growth failure are associated
with mitochondrial diseases, especially in patients with
MELAS. However, their growth parameters can be
affected by general condition, nutrition, and other asso-
ciated factors. Mitochondrial endocrinopathy should be
considered as a rare cause of endocrine dysfunction and
growth failure when clinically suspected.
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